These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3329522)

  • 1. A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression).
    Miller PS; Ts'o PO
    Anticancer Drug Des; 1987 Oct; 2(2):117-28. PubMed ID: 3329522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of ribonucleic acid function by oligonucleoside methylphosphonates.
    Miller PS; Agris CH; Aurelian L; Blake KR; Murakami A; Reddy MP; Spitz SA; Ts'o PO
    Biochimie; 1985; 67(7-8):769-76. PubMed ID: 3002493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
    Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemical cross-linking of psoralen-derivatized oligonucleoside methylphosphonates to rabbit globin messenger RNA.
    Kean JM; Murakami A; Blake KR; Cushman CD; Miller PS
    Biochemistry; 1988 Dec; 27(26):9113-21. PubMed ID: 2468360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1.
    Kulka M; Smith CC; Levis J; Fishelevich R; Hunter JC; Cushman CD; Miller PS; Ts'o PO; Aurelian L
    Antimicrob Agents Chemother; 1994 Apr; 38(4):675-80. PubMed ID: 8031030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5.
    Kulka M; Wachsman M; Miura S; Fishelevich R; Miller PS; Ts'o PO; Aurelian L
    Antiviral Res; 1993 Feb; 20(2):115-30. PubMed ID: 8384823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function.
    Lam Q; Smibert CA; Koop KE; Lavery C; Capone JP; Weinheimer SP; Smiley JR
    EMBO J; 1996 May; 15(10):2575-81. PubMed ID: 8665865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to chemotherapy based on base sequence information and nucleic acid chemistry. Matagen (masking tape for gene expression).
    Ts'o PO; Miller PS; Aurelian L; Murakami A; Agris C; Blake KR; Lin SB; Lee BL; Smith CC
    Ann N Y Acad Sci; 1987; 507():220-41. PubMed ID: 3327415
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisense oligonucleotide derivatives as gene-targeted drugs.
    Knorre DG; Vlassov VV
    Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcriptomes for serial analysis of gene expression].
    Marti J; Piquemal D; Manchon L; Commes T
    J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
    Mester JC; Pitha PM; Glorioso JC
    Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of chimeric genes in the early region of SV40.
    Horowitz M; Cepko CL; Sharp PA
    J Mol Appl Genet; 1983; 2(2):147-59. PubMed ID: 6192195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block polycationic oligonucleotide derivative: synthesis and inhibition of herpes virus reproduction.
    Vinogradov SV; Suzdaltseva YG; Kabanov AV
    Bioconjug Chem; 1996; 7(1):3-6. PubMed ID: 8741984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
    Chen YM; Knipe DM
    Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.